Weekly update|Companies|Recruiting|Promote|Post a job

Walking Fish Therapeutics

Founded: 2019

Location: South SF, CA

Employee range: 11 - 50

Clinical stage: RD

Therapy area: Solid tumors

Drug types: ONC, RAR

Lead product: WFT-1

Product link: https://www.walkingfishtx.com/

Funding: $73M A Feb 2022; $50M A Sep 2021

walkingfishtx.com

linkedin.com

job board

Short description:

Cell-Based Protein Factories to Treat Serious Disorders

Drug notes:

WFT-2 RD solid tumors; WFT-3 RD rare disease/regenerative medicine

Long description:

Walking Fish Therapeutics focuses on regenerative medicine and oncology solutions, inspired by the regenerative capabilities of the Axolotl. Their scientific focus revolves around developing B-cell based protein therapies to treat serious diseases, such as cancers and autoimmune conditions. Their engineered B-cells are used as potent protein and antibody factories with the potential for infectious, deficiency, and autoimmune diseases. Engineered B cells especially have great potential for cancer by improving the antitumor immune response. These B cells and CAR B cells can target specific tissues for a selective, local response. This advanced technology along with the team’s expertise in protein therapeutics and immuno-oncology holds promise for those with serious diseases and unmet medical needs.

Jobs:

Main

Contact: recruit@workinbiotech.com